Delphi-panel analysis of appropriateness of high-dose therapy and bone marrow transplants in chronic myelogenous leukemia in chronic phase

Clift, 1993, Treatment of chronic myeloid leukemia by marrow transplantation, Blood, 82, 1954, 10.1182/blood.V82.7.1954.1954 Passweg JR, Rowlings PA, Armitage JO, et al. Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry-North America. In: Cecka JM, Teraskaki PI, editors. Clinical Transplants, 1995. UCLA Tissue Typing Laboratory, Los Angeles, CA, 1996;117–27. Lee, 1997, Unrelated donor bone marrow transplantation for chronic myelogenous leukemia: a decision analysis, Ann. Intern. Med., 127, 1080, 10.7326/0003-4819-127-12-199712150-00005 Lee, 1998, Initial therapy for chronic myelogenous leukemia: playing the odds, J. Clin. Oncol., 16, 2897, 10.1200/JCO.1998.16.9.2897 Gale, 1998, Survival with bone marrow transplantation versus hydroxyurea or interferon for chronic myelogenous leukemias, Blood, 91, 1810 Buckner, 1995, Timing of allogeneic marrow transplants for patients with chronic myelogenous leukemia, Bone Marrow Transplant, 15 Suppl 1, S203 Goldman, 1993, Choice of pretransplant treatment and timing of transplants for chronic myelogenous leukemia in chronic phase, Blood, 82, 2235, 10.1182/blood.V82.7.2235.2235 Gratwohl, 1998, Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation, Lancet, 352, 1087, 10.1016/S0140-6736(98)03030-X Morton, 1997, Impact of pretransplant interferon-α (IFN) on outcome of unrelated donor marrow transplants for chronic myelogenous leukemias (CML) in first chronic phase, Blood, 90, 123a Giralt, 1993, Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia, J. Clin. Oncol., 11, 1055, 10.1200/JCO.1993.11.6.1055 Horowitz MM, Giralt SA, Szydlo R, et al. Effect of prior interferon therapy on outcome of HLA-identical sibling bone marrow transplants for chronic myelogenous leukemia (CML) in first chronic phase. Blood, 1996; 88:682a, (Abstr 2716). Brook, 1986, A method for the detailed assessment of the appropriateness of medical technologies, Intl. J. Tech. Assess. Health Care, 2, 53, 10.1017/S0266462300002774 Jones, 1986, Consensus methods for medical and health services research, Br. Med. J., 311, 376, 10.1136/bmj.311.7001.376 Woolf SH. Practice guidelines, a new reality in medicine, I: recent developments; and II. Methods of developing guidelines. Arch Intern Med, 1990; 150: 1811–8, and 1992; 152:946–52 Park, 1986, Physician ratings of appropriate indications for six medical and surgical procedures, Am. J. Publ. Health, 76, 766, 10.2105/AJPH.76.7.766 Gale, 1998, Delphi-consensus panel analysis of appropriateness of high-dose therapy and bone marrow transplants in acute lymphoblastic leukemia in 1st remission, Leuk. Res., 22, 973, 10.1016/S0145-2126(98)00085-X Gale RP, Park RE, Dubois R, et al. Delphi-consensus panel analysis of appropriateness of high-dose therapy and bone marrow transplants in acute myelogenous leukemia in 1st remission. Leuk Res 1999;23:709–18. Sokal, 1984, Prognostic discrimination in ‘good-risk’ chronic granulocytic leukemia, Blood, 63, 789, 10.1182/blood.V63.4.789.789 Sokal, 1985, Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation, Blood, 66, 1326, 10.1182/blood.V66.6.1352.1352 Breiman, 1984, 75 Shekelle PG, Chassin MR, Park RE. Evidence for the validity of criteria for performing carotid endarterectomy. Int J Tech Assess Health Care 1998;14:707–27. Kravitz, 1995, Validity of criteria used for detecting underuse of coronary revascularization, J. Am. Med. Ass., 274, 632, 10.1001/jama.274.8.632 Selby, 1996, Variation among hospitals in coronary-angiography practices and outcomes after myocardial infarction in a large health maintenance organization, New Engl. J. Med., 335, 1888, 10.1056/NEJM199612193352506 Shekelle, 1998, Reproducibility of the method to identify the overuse and underuse of medical procedures, New Engl. J. Med., 338, 1888, 10.1056/NEJM199806253382607 Hansen, 1998, Bone marrow transplants from unrelated donor for patients with chronic myeloid leukemia, New Engl. J. Med., 338, 962, 10.1056/NEJM199804023381405